Literature DB >> 23624807

2-Phenylpyridine ruthenacycles as effectors of glucose oxidase activity: inhibition by Ru(II) and activation by Ru(III).

Rafael Omar Saavedra Díaz1, Ronan Le Lagadec, Alexander D Ryabov.   

Abstract

Cyclometalated Ru(II) derivatives of 2-phenylpyridine (Hphpy) [Ru(phpy)(bpy)2]Cl (1a) and [Ru(phpy)(phen)2]Cl (1b) (bpy is 2,2'-bipyridine, phen is 1,10-phenanthroline) behave as noncompetitive inhibitors of glucose oxidase from Aspergillus niger in the enzyme-catalyzed oxidation of D-glucose by O2 into the corresponding lactone at pH 5.0 and 25 °C. The enzymatic activity has been measured by monitoring the O2 consumption. The inhibition constants K i are 0.036 and 0.017 M for 1a and 1b, respectively, indicating that 1b inhibits the enzymatic activity more efficiently than 1a. The well-known coordination compound [Ru(bpy)3]Cl2 (2) behaves, in contrast, as a competitive inhibitor, with K i = 0.018 M under the same conditions. The monophasic consumption of O2 in the case of 1a, 1b, and 2 is replaced by a distinct two-phase kinetics in the presence of the cyclometalated Ru(III) compound [Ru(phpy)(bpy)2]Cl2 (3), which was obtained from 1a in the presence of a large excess of H2O2 and the iron TAML activator. Interestingly, the rates of the first and the second phases are influenced by 3 in a different way. The rate of the first phase is noticeably higher in the presence of Ru(III), although the dependence is nonmonotonic and maximal acceleration is observed at the lowest loadings of 3. The rate of the second phase decreases monotonically on increasing the concentration of the ruthenium complex in solution. The nonmonotonic action of 3 was confirmed by using the doubly cyclometalated Ru(III) derivative [Ru(phpy)2(bpy)]Cl. The diverse rate variations induced by 3 accounted for acceleration by Ru(III) of the O2 reduction by the reduced form of glucose oxidase during the first phase, which ceases after the enzymatic reduction of Ru(III) to the Ru(II) species, the latter behaving similarly to 1a as the inhibitor of the enzyme.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23624807     DOI: 10.1007/s00775-013-0999-z

Source DB:  PubMed          Journal:  J Biol Inorg Chem        ISSN: 0949-8257            Impact factor:   3.358


  18 in total

1.  New synthesis and new bio-application of cyclometalated ruthenium(II) complexes for fast mediated electron transfer with peroxidase and glucose oxidase.

Authors:  A D Ryabov; V S Sukharev; L Alexandrova; R Le Lagadec; M Pfeffer
Journal:  Inorg Chem       Date:  2001-12-03       Impact factor: 5.165

2.  Biochemical origins of the non-monotonic receptor-mediated dose-response.

Authors:  M C Kohn; R L Melnick
Journal:  J Mol Endocrinol       Date:  2002-08       Impact factor: 5.098

3.  Low-potential cyclometalated osmium(II) mediators of glucose oxidase.

Authors:  Alexander D Ryabov; Valentin S Soukharev; Larissa Alexandrova; Ronan Le Lagadec; Michel Pfeffer
Journal:  Inorg Chem       Date:  2003-10-20       Impact factor: 5.165

Review 4.  Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses.

Authors:  Laura N Vandenberg; Theo Colborn; Tyrone B Hayes; Jerrold J Heindel; David R Jacobs; Duk-Hee Lee; Toshi Shioda; Ana M Soto; Frederick S vom Saal; Wade V Welshons; R Thomas Zoeller; John Peterson Myers
Journal:  Endocr Rev       Date:  2012-03-14       Impact factor: 19.871

5.  Library of second-generation cycloruthenated compounds and evaluation of their biological properties as potential anticancer drugs: passing the nanomolar barrier.

Authors:  Ludivine Fetzer; Bastien Boff; Moussa Ali; Meng Xiangjun; Jean-Paul Collin; Claude Sirlin; Christian Gaiddon; Michel Pfeffer
Journal:  Dalton Trans       Date:  2011-08-12       Impact factor: 4.390

6.  Modeling non-monotonic dose-response relationships: model evaluation and hormetic quantities exploration.

Authors:  Xiang-Wei Zhu; Shu-Shen Liu; Li-Tang Qin; Fu Chen; Hai-Ling Liu
Journal:  Ecotoxicol Environ Saf       Date:  2012-12-21       Impact factor: 6.291

7.  The glucose oxidase mechanism. Interpretation of the pH dependence.

Authors:  M K Weibel; H J Bright
Journal:  J Biol Chem       Date:  1971-05-10       Impact factor: 5.157

8.  Easy access to bio-inspired osmium(II) complexes through electrophilic intramolecular C(sp2)-H bond cyclometalation.

Authors:  Ricardo Cerón-Camacho; David Morales-Morales; Simon Hernandez; Ronan Le Lagadec; Alexander D Ryabov
Journal:  Inorg Chem       Date:  2008-05-06       Impact factor: 5.165

9.  Biochemical characterization of human prolyl hydroxylase domain protein 2 variants associated with erythrocytosis.

Authors:  Melissa B Pappalardi; John D Martin; Yong Jiang; Matthew C Burns; Huizhen Zhao; Thau Ho; Sharon Sweitzer; Leng Lor; Benjamin Schwartz; Kevin Duffy; Richard Gontarek; Peter J Tummino; Robert A Copeland; Lusong Luo
Journal:  Biochemistry       Date:  2008-10-04       Impact factor: 3.162

Review 10.  Role and regulation of prolyl hydroxylase domain proteins.

Authors:  G-H Fong; K Takeda
Journal:  Cell Death Differ       Date:  2008-02-15       Impact factor: 15.828

View more
  1 in total

Review 1.  Targeting of the intracellular redox balance by metal complexes towards anticancer therapy.

Authors:  María Isabel Murillo; Christian Gaiddon; Ronan Le Lagadec
Journal:  Front Chem       Date:  2022-08-11       Impact factor: 5.545

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.